Position in DNLI
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$9,830
-$103,723 QoQ
Shares Held
512
-86.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Quantbot Technologies LP holds $29,328,891 across 118 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
80,193 | $4,496,421 | |
| 2 | TECH |
BIO-TECHNE Corp
|
52,802 | $3,730,461 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
5,724 | $1,071,990 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
17,880 | $975,175 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,460 | $910,368 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
10,831 | $882,834 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
6,302 | $836,464 | |
| 8 | SYRE |
Spyre Therapeutics, Inc.
|
8,884 | $788,721 |
All Filings in DNLI
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,830 | 512 | Shares | Sole | 2026-05-13 | |
| 2022-09-30 | $113,553 | 3,700 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $23,544 | 800 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $5,372 | 167 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $166,893 | 3,742 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $21,743 | 431 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $102,442 | 1,306 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $407,065 | 7,129 | Shares | Sole | 2021-05-14 | |
| 2020-09-30 | $106,809 | 2,981 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||